Quality of life after starting highly active antiretroviral therapy for chronic HIV-1 infection at different CD4 cell counts

被引：6
|
作者：
Nieuwkerk, Pythia T.
Hillebrand-Haverkort, Milly E.
Vriesendorp, Robert
Frissen, P. H. Jos
de Wolf, Frank
Sprangers, Mirjam A. G.
机构：
[1] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Medisch Centrum Alkmaar, Alkmaar, Netherlands
[3] Medsch Centrum Haaglanden, The Hague, Netherlands
[4] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands
[5] HIV Monitoring Fdn, Amsterdam, Netherlands
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2007年 / 45卷 / 05期
关键词：
D O I：
10.1097/QAI.0b013e318074efbf
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：600 / 601
页数：2
相关论文
共 50 条
  • [1] CD4 Cell Responses to Combination Antiretroviral Therapy in Patients Starting Therapy at High CD4 Cell Counts
    Wright, Stephen T.
    Carr, Andrew
    Woolley, Ian
    Giles, Michelle
    Hoy, Jennifer
    Cooper, David A.
    Law, Matthew G.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 58 (01) : 72 - 79
  • [2] Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover
    Anthony, KB
    Yoder, C
    Metcalf, JA
    DerSimonian, R
    Orenstein, JM
    Stevens, RA
    Falloon, J
    Polis, MA
    Lane, HC
    Sereti, I
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (02) : 125 - 133
  • [3] Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions
    Jansen, CA
    De Cuyper, IM
    Steingrover, R
    Jurriaans, S
    Sankatsing, SUC
    Prins, JM
    Lange, JMA
    van Baarle, D
    Miedema, F
    AIDS, 2005, 19 (11) : 1145 - 1154
  • [4] CD4 T Cell Count Reconstitution in HIV Controllers after Highly Active Antiretroviral Therapy
    Okulicz, Jason F.
    Grandits, Greg A.
    Weintrob, Amy C.
    Landrum, Michael L.
    Ganesan, Anuradha
    Crum-Cianflone, Nancy F.
    Agan, Brian K.
    Marconi, Vincent C.
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (08) : 1187 - 1191
  • [5] HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy
    Sterling, TR
    Chaisson, RE
    Moore, RD
    AIDS, 2001, 15 (17) : 2251 - 2257
  • [6] Viral load trend in HIV-1 seropositive patients with different CD4 cell counts before starting HAART
    Re, MC
    Ramazzotti, E
    Manfredi, R
    Furlini, G
    Vignoli, M
    Maldini, C
    Borderi, M
    La Placa, M
    JOURNAL OF CLINICAL VIROLOGY, 2000, 17 (01) : 5 - 11
  • [7] Development and Validation of Decision Rules to Guide Frequency of Monitoring CD4 Cell Count in HIV-1 Infection before Starting Antiretroviral Therapy
    Buclin, Thierry
    Telenti, Amalio
    Perera, Rafael
    Csajka, Chantal
    Furrer, Hansjakob
    Aronson, Jeffrey K.
    Glasziou, Paul P.
    PLOS ONE, 2011, 6 (04):
  • [8] Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease
    Kalayjian, Robert C.
    Franceschini, Nora
    Gupta, Samir K.
    Szczech, Lynda A.
    Mupere, Ezekiel
    Bosch, Ronald J.
    Smurzynski, Marlene
    Albert, Jeffrey M.
    AIDS, 2008, 22 (04) : 481 - 487
  • [9] Evidence of thymic reconstitution after highly active antiretroviral therapy in HIV-1 infection
    Hardy, G
    Worrell, S
    Hayes, P
    Barnett, CM
    Glass, D
    Pido-Lopez, J
    Imami, N
    Aspinall, R
    Dutton, J
    Gazzard, B
    Peters, AM
    Gotch, FM
    HIV MEDICINE, 2004, 5 (02) : 67 - 73
  • [10] Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level
    Viard, JP
    Burgard, M
    Hubert, JB
    Aaron, L
    Rabian, C
    Pertuiset, N
    Lourenço, M
    Rothschild, C
    Rouzioux, C
    AIDS, 2004, 18 (01) : 45 - 49
12345